-
1.3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands 有权
标题翻译: 3,4-DI取代的环丁烯-1,2-二酮作为CXC-趋化因子受体配体公开(公告)号:US07964646B2
公开(公告)日:2011-06-21
申请号:US11500739
申请日:2006-08-08
申请人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, Jr. , Laura L. Rokosz , Gaifa Lai
发明人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, Jr. , Laura L. Rokosz , Gaifa Lai
IPC分类号: C07C233/00 , A01N37/18
CPC分类号: C07C237/30 , C07C225/20 , C07C237/36 , C07C237/44 , C07C255/59 , C07C311/39 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D207/335 , C07D213/74 , C07D217/24 , C07D295/26 , C07D307/38 , C07D307/52 , C07D307/68 , C07D307/81 , C07D307/82 , C07D307/83 , C07D317/46 , C07D319/18 , C07D333/20 , C07D333/36 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14
摘要: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
摘要翻译: 公开了可用于治疗趋化因子介导的疾病如急性和慢性炎症性疾病和癌症的下式的化合物或其药学上可接受的盐或溶剂合物。
-
2.3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands 有权
标题翻译: 3,4-二取代的环丁烯-1,2-二酮作为CXC-趋化因子受体配体公开(公告)号:US07947720B2
公开(公告)日:2011-05-24
申请号:US12352781
申请日:2009-01-13
申请人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, Jr. , Laura L. Rokosz
发明人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, Jr. , Laura L. Rokosz
IPC分类号: C07D261/04 , C07D327/04 , A01N43/80 , A01N43/06
CPC分类号: C07C237/30 , C07C225/20 , C07C237/36 , C07C237/44 , C07C255/59 , C07C311/39 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D207/335 , C07D213/74 , C07D217/24 , C07D295/26 , C07D307/38 , C07D307/52 , C07D307/68 , C07D307/81 , C07D307/82 , C07D307/83 , C07D317/46 , C07D319/18 , C07D333/20 , C07D333/36 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14
摘要: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
摘要翻译: 公开了可用于治疗趋化因子介导的疾病如急性和慢性炎症性疾病和癌症的下式的化合物或其药学上可接受的盐或溶剂合物。
-
3.3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists 失效
标题翻译: 3,4-二取代的哒嗪二酮作为CXC趋化因子受体拮抗剂公开(公告)号:US06878709B2
公开(公告)日:2005-04-12
申请号:US10335789
申请日:2003-01-02
申请人: Arthur G. Taveras , Michael Dwyer , Jianping Chao , John J. Baldwin , J. Robert Merritt , Ge Li , Jianhua Chao , Younong Yu
发明人: Arthur G. Taveras , Michael Dwyer , Jianping Chao , John J. Baldwin , J. Robert Merritt , Ge Li , Jianhua Chao , Younong Yu
IPC分类号: A61K31/50 , A61K31/501 , A61K31/506 , A61K31/5377 , A61K45/00 , A61P1/02 , A61P1/04 , A61P7/02 , A61P9/00 , A61P9/10 , A61P9/14 , A61P11/00 , A61P11/06 , A61P13/12 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/28 , A61P27/02 , A61P31/04 , A61P31/12 , A61P31/14 , A61P31/18 , A61P31/20 , A61P31/22 , A61P33/06 , A61P35/00 , A61P37/02 , A61P37/04 , A61P39/00 , A61P43/00 , C07D237/22 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D409/14 , C07D417/12
CPC分类号: C07D403/12 , C07D237/22 , C07D405/12 , C07D409/12 , C07D417/12
摘要: Disclosed are compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
摘要翻译: 公开了式(I)化合物或其药学上可接受的盐或溶剂化物。 该化合物可用于治疗趋化因子介导的疾病,例如急性和慢性炎症性疾病和癌症。
-
4.3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands 审中-公开
标题翻译: 3,4-二取代的环丁烯-1,2-二酮作为CXC趋化因子受体配体公开(公告)号:US20110213029A1
公开(公告)日:2011-09-01
申请号:US13102554
申请日:2011-05-06
申请人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, JR. , Laura L. Rokosz , Gaifa Lai , James P. Jakway , Minglang Wu , Evan A. Hecker , Daniel Lundell , Jay S. Fine
发明人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, JR. , Laura L. Rokosz , Gaifa Lai , James P. Jakway , Minglang Wu , Evan A. Hecker , Daniel Lundell , Jay S. Fine
IPC分类号: A61K31/341 , A61P11/00
CPC分类号: C07C237/30 , C07C225/20 , C07C237/36 , C07C237/44 , C07C255/59 , C07C311/39 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D207/335 , C07D213/74 , C07D217/24 , C07D295/26 , C07D307/38 , C07D307/52 , C07D307/68 , C07D307/81 , C07D307/82 , C07D307/83 , C07D317/46 , C07D319/18 , C07D333/20 , C07D333/36 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14
摘要: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
摘要翻译: 公开了可用于治疗趋化因子介导的疾病如急性和慢性炎症性疾病和癌症的下式的化合物或其药学上可接受的盐或溶剂合物。
-
5.3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS 有权
标题翻译: 作为CXC-CHEMOKINE受体配体的3,4-二取代的环己基-1,2-二酮公开(公告)号:US20090306079A1
公开(公告)日:2009-12-10
申请号:US12352781
申请日:2009-01-13
申请人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, JR. , Laura L. Rokosz , Gaifa Lai , James P. Jakway , Minglang Wu , Evan A. Hecker , Daniel Lundell , Jay S. Fine
发明人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, JR. , Laura L. Rokosz , Gaifa Lai , James P. Jakway , Minglang Wu , Evan A. Hecker , Daniel Lundell , Jay S. Fine
IPC分类号: A61K31/535 , C07D401/04 , C07D295/14 , A61P37/02 , A61P9/12 , A61K31/497
CPC分类号: C07C237/30 , C07C225/20 , C07C237/36 , C07C237/44 , C07C255/59 , C07C311/39 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D207/335 , C07D213/74 , C07D217/24 , C07D295/26 , C07D307/38 , C07D307/52 , C07D307/68 , C07D307/81 , C07D307/82 , C07D307/83 , C07D317/46 , C07D319/18 , C07D333/20 , C07D333/36 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14
摘要: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
摘要翻译: 公开了可用于治疗趋化因子介导的疾病如急性和慢性炎症性疾病和癌症的下式的化合物或其药学上可接受的盐或溶剂合物。
-
6.3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands 有权
标题翻译: 3,4-二取代的环丁烯-1,2-二酮作为CXC-趋化因子受体配体公开(公告)号:US07132445B2
公开(公告)日:2006-11-07
申请号:US10630258
申请日:2003-07-30
申请人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, Jr. , Laura L. Rokosz , James P. Jakway , Gaifa Lai , Minglang Wu , Evan A. Hecker , Daniel Lundell , Jay S. Fine
发明人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, Jr. , Laura L. Rokosz , James P. Jakway , Gaifa Lai , Minglang Wu , Evan A. Hecker , Daniel Lundell , Jay S. Fine
IPC分类号: A61K31/341 , A61K31/343 , A61K31/381 , C07D333/10 , C07D33/72
CPC分类号: C07D207/335 , C07C225/20 , C07C237/30 , C07C237/36 , C07C237/44 , C07C255/59 , C07C311/39 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D213/74 , C07D217/24 , C07D295/26 , C07D307/38 , C07D307/52 , C07D307/68 , C07D307/81 , C07D307/82 , C07D307/83 , C07D317/46 , C07D319/18 , C07D333/20 , C07D333/36 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14
摘要: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
摘要翻译: 公开了可用于治疗趋化因子介导的疾病如急性和慢性炎症性疾病和癌症的下式的化合物或其药学上可接受的盐或溶剂合物。
-
7.Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands 失效
标题翻译: 噻二唑二氧化物和噻二唑氧化物作为CXC-和CC-趋化因子受体配体公开(公告)号:US07691856B2
公开(公告)日:2010-04-06
申请号:US11651128
申请日:2007-01-09
申请人: Arthur G. Taveras , Jianhua Chao , Purakkattle J. Biju , Younong Yu , Cynthia J. Aki , J. Robert Merritt , Ge Li , John J. Baldwin , Gaifa Lai , Minglang Wu , Evan A. Hecker
发明人: Arthur G. Taveras , Jianhua Chao , Purakkattle J. Biju , Younong Yu , Cynthia J. Aki , J. Robert Merritt , Ge Li , John J. Baldwin , Gaifa Lai , Minglang Wu , Evan A. Hecker
IPC分类号: A61K31/496 , A61K31/4453 , A61K31/5355 , C07D285/06 , C07D417/14
CPC分类号: C07D285/10 , C07D417/02 , C07D417/12 , C07D417/14
摘要: Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula IA.
摘要翻译: 公开了下式的新化合物及其药学上可接受的盐和溶剂合物。 包含取代基A的基团的实例包括杂芳基,芳基,杂环烷基,环烷基,芳基,炔基,烯基,氨基烷基,烷基或氨基。 包含取代基B的基团的实例包括芳基和杂芳基。 还公开了治疗趋化因子介导的疾病如癌症,血管生成,血管生成性眼病,肺部疾病,多发性硬化,类风湿性关节炎,骨关节炎,中风和心脏再灌注损伤,急性疼痛,急性和慢性炎症性疼痛的方法 使用式IA化合物的神经性疼痛。
-
8.3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists 失效
标题翻译: 3,4-二取代的马来酰亚胺化合物作为CXC趋化因子受体拮抗剂公开(公告)号:US06903131B2
公开(公告)日:2005-06-07
申请号:US10269775
申请日:2002-10-11
申请人: Arthur G. Taveras , Michael Dwyer , Johan A. Ferreira , Viyyoor M. Girijavallabhan , Jianping Chao , John J. Baldwin , J. Robert Merritt , Ge Li
发明人: Arthur G. Taveras , Michael Dwyer , Johan A. Ferreira , Viyyoor M. Girijavallabhan , Jianping Chao , John J. Baldwin , J. Robert Merritt , Ge Li
IPC分类号: A61K31/337 , A61K31/4015 , A61K31/402 , A61K31/4025 , A61K31/4155 , A61K31/4192 , A61K31/4439 , A61K31/454 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/56 , A61K38/00 , A61K38/21 , A61K38/22 , A61K38/55 , A61K39/395 , A61K45/00 , A61P1/02 , A61P1/04 , A61P1/16 , A61P1/18 , A61P3/10 , A61P7/02 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/06 , A61P11/08 , A61P11/10 , A61P13/12 , A61P17/02 , A61P17/06 , A61P19/02 , A61P19/06 , A61P19/10 , A61P21/00 , A61P25/00 , A61P25/28 , A61P27/02 , A61P31/04 , A61P31/18 , A61P31/20 , A61P31/22 , A61P35/00 , A61P37/06 , A61P37/08 , A61P43/00 , C07D207/44 , C07D207/456 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D409/14 , C07D417/12
CPC分类号: C07D207/456 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D409/14 , C07D417/12
摘要: Disclosed are compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
摘要翻译: 公开了式(I)化合物或其药学上可接受的盐或溶剂化物。 该化合物可用于治疗趋化因子介导的疾病,例如急性和慢性炎症性疾病和癌症。
-
9.3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands 有权
标题翻译: 3,4-二取代的环丁烯-1,2-二酮作为CXC-趋化因子受体配体公开(公告)号:US20070021494A1
公开(公告)日:2007-01-25
申请号:US11500739
申请日:2006-08-08
申请人: Arthur Taveras , Cynthia Aki , Richard Bond , Jianping Chao , Michael Dwyer , Johan Ferreira , Jianhua Chao , Younong Yu , John Baldwin , Bernd Kaiser , Ge Li , J. Merritt , Purakkattle Biju , Kingsley Nelson , Laura Rokosz , Gaifa Lai , James Jakway , Minglang Wu , Evan Hecker , Daniel Lundell , Jay Fine
发明人: Arthur Taveras , Cynthia Aki , Richard Bond , Jianping Chao , Michael Dwyer , Johan Ferreira , Jianhua Chao , Younong Yu , John Baldwin , Bernd Kaiser , Ge Li , J. Merritt , Purakkattle Biju , Kingsley Nelson , Laura Rokosz , Gaifa Lai , James Jakway , Minglang Wu , Evan Hecker , Daniel Lundell , Jay Fine
IPC分类号: A61K31/4709 , A61K31/4436 , A61K31/427 , A61K31/422 , A61K31/4178 , A61K31/381 , C07D409/02 , C07D413/02 , C07D417/02
CPC分类号: C07C237/30 , C07C225/20 , C07C237/36 , C07C237/44 , C07C255/59 , C07C311/39 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D207/335 , C07D213/74 , C07D217/24 , C07D295/26 , C07D307/38 , C07D307/52 , C07D307/68 , C07D307/81 , C07D307/82 , C07D307/83 , C07D317/46 , C07D319/18 , C07D333/20 , C07D333/36 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14
摘要: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
摘要翻译: 公开了可用于治疗趋化因子介导的疾病如急性和慢性炎症性疾病和癌症的下式的化合物或其药学上可接受的盐或溶剂合物。
-
公开(公告)号:US06432959B1
公开(公告)日:2002-08-13
申请号:US09469465
申请日:1999-12-22
申请人: Alan B. Cooper , Ronald J. Doll , Johan A. Ferreira , Ashit Ganguly , Viyyoor M. Girijavallabhan , Arthur G. Taveras , Jianping Chao , John J. Baldwin , Chia-Yu Huang , Ge Li
发明人: Alan B. Cooper , Ronald J. Doll , Johan A. Ferreira , Ashit Ganguly , Viyyoor M. Girijavallabhan , Arthur G. Taveras , Jianping Chao , John J. Baldwin , Chia-Yu Huang , Ge Li
IPC分类号: A61K31496
CPC分类号: C07D401/14 , C07D403/12 , C07D417/14
摘要: Novel compounds and pharmaceutical compositions are disclosed which are inhibitors of the enzyme, farnesyl protein transferase. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering the novel aminooxyamide compound to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammals such as a human.
摘要翻译: 公开了新的化合物和药物组合物,其是酶的法呢基蛋白转移酶的抑制剂。 还公开了抑制Ras功能并因此抑制细胞异常生长的方法。 该方法包括将新的氨氧基酰胺化合物施用于生物系统。 特别地,该方法抑制哺乳动物如人的细胞的异常生长。
-
-
-
-
-
-
-
-
-